Survey to Assess Potential Acceptance of COVID 19 Vaccine in Pregnant and Lactating Wome
Not Applicable
- Registration Number
- CTRI/2021/04/032615
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant and Lactating Women
Exclusion Criteria
Women who are surrogates are not eligible for the study
Women who are not willing to participate due to any reason
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method at the end of the survey we will be able to determine prevalence and acceptance of COVID 19 vaccine in pregnant and lactating populationTimepoint: 24 weeks
- Secondary Outcome Measures
Name Time Method Barriers faced by pregnant and lactating women to get vaccinatedTimepoint: 24 weeks